Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets

J Gong, S Hu, Q Shan, J Qin, N Han… - … Advances in Medical …, 2024 - journals.sagepub.com
Background: Bone metastasis (BM) seriously affects the quality of life and reduces the
survival time of patients with non-small-cell lung cancer (NSCLC). The genomic …

Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets

J Gong, S Hu, Q Shan, J Qin… - … advances in medical …, 2024 - pubmed.ncbi.nlm.nih.gov
Background Bone metastasis (BM) seriously affects the quality of life and reduces the
survival time of patients with non-small-cell lung cancer (NSCLC). The genomic …

Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets.

J Gong, S Hu, Q Shan, J Qin, N Han… - … Advances in Medical …, 2024 - search.ebscohost.com
Background: Bone metastasis (BM) seriously affects the quality of life and reduces the
survival time of patients with non-small-cell lung cancer (NSCLC). The genomic …

Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets.

J Gong, S Hu, Q Shan, J Qin, N Han… - Therapeutic Advances in …, 2024 - europepmc.org
Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of
potential targets. - Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe …

[HTML][HTML] Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets

J Gong, S Hu, Q Shan, J Qin, N Han… - … Advances in Medical …, 2024 - ncbi.nlm.nih.gov
Background: Bone metastasis (BM) seriously affects the quality of life and reduces the
survival time of patients with non-small-cell lung cancer (NSCLC). The genomic …

Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets

J Gong, S Hu, Q Shan, J Qin, N Han, F Xie, H Lu - 2024 - europepmc.org
Background: Bone metastasis (BM) seriously affects the quality of life and reduces the
survival time of patients with non-small-cell lung cancer (NSCLC). The genomic …